Mid-term outcomes of patients with Lotus and Evolut transcatheter valves
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F22%3A10446552" target="_blank" >RIV/00064203:_____/22:10446552 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/22:10446552 RIV/00216208:11310/22:10446552
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UavPXgY9OM" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=UavPXgY9OM</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/aic.2022.118531" target="_blank" >10.5114/aic.2022.118531</a>
Alternative languages
Result language
angličtina
Original language name
Mid-term outcomes of patients with Lotus and Evolut transcatheter valves
Original language description
Introduction: Long-term data on the Lotus (R) (Boston Scientific, USA) valve are lacking. Aim: To evaluate mid-term outcomes of aortic stenosis patients treated with either Lotus or Evolut R (R) valves (Medtronic, USA). Material and methods: Our study sample comprised 190 patients (71 Lotus and 119 Evolut valves). The mean clinical follow-up was 2.0 +/- 0.9 years. Information on mortality was obtained from the National Institutes of Health Information and Statistics. Results: No significant differences existed in baseline characteristics between the groups. The rate of procedural complications was low and without significant differences between groups. The log rank test showed higher mortality in the Lotus group for cardiovascular mortality (p = 0.02; RR = 2.4, 95% CI: 1.123-5.075). Multivariable analysis revealed that the Lotus valve was independently associated with cardiovascular mortality (p = 0.03). At the end of echocardiography follow-up (4.1 +/- 0.9 years), we found a significantly higher mean aortic valve gradient (AVGm) in the Lotus group than in the Evolut group (17.9 +/- 9.5 vs. 10.2 +/- 3.5 mm Hg; p = 0.0006), and 3 (10%) patients from the Lotus group suffered from symptomatic re-stenosis requiering re-intervention. Conclusions: The results of our study suggest that higher cardiovascular mortality rates during mid-term follow-up were associated with Lotus compared with Evolut valves. Higher AVGm in the Lotus valves suggests the possibility of accelerated prosthesis degeneration.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej
ISSN
1734-9338
e-ISSN
1897-4295
Volume of the periodical
18
Issue of the periodical within the volume
2
Country of publishing house
PL - POLAND
Number of pages
8
Pages from-to
146-153
UT code for WoS article
000844053600008
EID of the result in the Scopus database
2-s2.0-85138644455